PERSPECTIVE THERAPEUTICS, INC. Operating Lease Right-of-Use Assets
PERSPECTIVE THERAPEUTICS, INC. (CATX) had Operating Lease Right-of-Use Assets of $2.20 million as of 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:OperatingLeaseRightOfUseAsset · last filed 2026-08-10
- 2026-06-30: Operating Lease, Right-of-Use Asset $2.20M.
- 2026-03-31: Operating Lease, Right-of-Use Asset $2.44M.
- 2025-12-31: Operating Lease, Right-of-Use Asset $1.50M.
- 2025-09-30: Operating Lease, Right-of-Use Asset $1.54M.
| Period end | Operating Lease, Right-of-Use Asset | Operating Lease, Right-of-Use Asset as first filed |
|---|---|---|
| 2026-06-30 | $2.20M 10-Q · filed 2026-08-10 | |
| 2026-03-31 | $2.44M 10-Q · filed 2026-05-11 | |
| 2025-12-31 | $1.50M 10-Q · filed 2026-08-10 | |
| 2025-09-30 | $1.54M 10-Q · filed 2025-11-10 | |
| 2025-06-30 | $1.77M 10-Q · filed 2025-08-13 | |
| 2025-03-31 | $1.99M 10-Q · filed 2025-05-12 | |
| 2024-12-31 | $2.21M 10-K · filed 2026-03-16 | |
| 2024-09-30 | $2.43M 10-Q · filed 2024-11-12 | |
| 2024-06-30 | $2.02M 10-Q · filed 2024-08-13 | |
| 2024-03-31 | $1.06M 10-Q · filed 2024-05-15 | |
| 2023-12-31 | $747.00K 10-K/A · filed 2025-03-28 | |
| 2023-09-30 | $1.53M 10-Q · filed 2023-11-14 | |
| 2023-06-30 | $805.00K 10-Q · filed 2023-08-11 | |
| 2023-03-31 | $309.00K 10-Q · filed 2023-05-15 | |
| 2022-12-31 | $0.00 10-K · filed 2024-03-28 | $378.00K 10-KT · filed 2023-05-01 |
| 2022-09-30 | $445.00K 10-Q · filed 2022-11-14 | |
| 2022-06-30 | $512.00K 10-KT · filed 2023-05-01 | |
| 2022-03-31 | $577.00K 10-Q · filed 2022-05-13 | |
| 2021-12-31 | $642.00K 10-Q · filed 2022-02-09 | |
| 2021-09-30 | $705.00K 10-Q · filed 2021-11-10 | |
| 2021-06-30 | $768.00K 10-KT · filed 2023-05-01 | |
| 2021-03-31 | $830.00K 10-Q · filed 2021-05-14 | |
| 2020-12-31 | $891.00K 10-Q · filed 2021-02-09 | |
| 2020-09-30 | $951.00K 10-Q · filed 2020-11-13 | |
| 2020-06-30 | $1.00M 10-K · filed 2021-09-27 | |
| 2020-03-31 | $1.06M 10-Q · filed 2020-05-13 | |
| 2019-12-31 | $1.12M 10-Q · filed 2020-02-12 | |
| 2019-09-30 | $1.17M 10-Q · filed 2019-11-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Upstream Bio, Inc. (UPB) | United States | $0.284B | -2.42 |
| Contineum Therapeutics, Inc. (CTNM) | United States | $0.289B | -4.40 |
| Sagimet Biosciences Inc. (SGMT) | United States | $0.279B | |
| Fulcrum Therapeutics, Inc. (FULC) | United States | $0.289B | -3.28 |
| ROCKET PHARMACEUTICALS, INC. (RCKT) | United States | $0.296B | -21.78 |
| STANDARD BIOTOOLS INC. (LAB) | United States | $0.297B | 3.80 |
| Mereo BioPharma Group plc (MREO) | $0.269B | -9.41 | |
| Vanda Pharmaceuticals Inc. (VNDA) | United States | $0.302B | -1.35 |
| Greenwich LifeSciences, Inc. (GLSI) | United States | $0.267B | -15.02 |
| GT Biopharma, Inc. (GTBP) | United States | $0.309B | -4.58 |